Norges Bank’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-490,206
Closed -$25.7M 340
2025
Q4
$25.7M Buy
+490,206
New +$29.4M ﹤0.01% 1193
2025
Q3
Sell
-406,487
Closed -$19.8M 378
2025
Q2
$19.8M Sell
406,487
-49,573
-11% -$1.92M ﹤0.01% 1190
2025
Q1
$15.5M Buy
456,060
+12,524
+3% +$531K ﹤0.01% 1227
2024
Q4
$17.5M Buy
443,536
+31,928
+8% +$1.51M ﹤0.01% 1254
2024
Q3
$19.3M Sell
411,608
-238,600
-37% -$12.1M ﹤0.01% 1230
2024
Q2
$35.1M Buy
650,208
+59,940
+10% +$3.47M 0.01% 1050
2024
Q1
$40.2M Sell
590,268
-27,318
-4% -$1.96M 0.01% 1041
2023
Q4
$38.7M Buy
617,586
+31,286
+5% +$1.73M 0.01% 1024
2023
Q3
$26.6M Buy
586,300
+9,267
+2% +$479K 0.01% 1113
2023
Q2
$32.4M Sell
577,033
-52,619
-8% -$2.99M 0.01% 1058
2023
Q1
$28.5M Sell
629,652
-85,776
-12% -$4.17M 0.01% 1099
2022
Q4
$29.1M Buy
715,428
+48,660
+7% +$2.58M 0.01% 1096
2022
Q3
$43.6M Buy
666,768
+76,191
+13% +$5.52M 0.01% 829
2022
Q2
$35.9M Sell
590,577
-23,256
-4% -$1.37M 0.01% 940
2022
Q1
$38.5M Buy
613,833
+21,096
+4% +$1.32M 0.01% 1025
2021
Q4
$44.9M Sell
592,737
-72,870
-11% -$6.37M 0.01% 1007
2021
Q3
$74.5M Buy
665,607
+41,517
+7% +$5.21M 0.02% 742
2021
Q2
$101M Buy
624,090
+67,829
+12% +$8.25M 0.02% 640
2021
Q1
$67.8M Sell
556,261
-6,830
-1% -$1.03M 0.02% 798
2020
Q4
$86.2M Sell
563,091
-9,296
-2% -$1.1M 0.02% 656
2020
Q3
$47.9M Buy
572,387
+73,909
+15% +$6.56M 0.01% 860
2020
Q2
$36.6M Buy
498,478
+335,761
+206% +$19.6M 0.01% 1050
2020
Q1
$6.9M Buy
162,717
+142,557
+707% +$7.36M ﹤0.01% 1742
2019
Q4
$1.23M Hold
20,160
﹤0.01% 2010
2019
Q3
$826K Buy
+20,160
New +$963K ﹤0.01% 2043

Other funds holding CRSP